Avenue Therapeutics Inc (ATXI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.3630 +0.0030 (+0.83%) 03/25/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.3630 unch (unch) 15:20 ET
for Tue, Mar 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Cash Flows From Operating Activities | |||||
Net Income | -10,137 | -7,050 | -4,349 | -10,488 | -11,105 |
Accounts receivable | N/A | N/A | N/A | N/A | -13 |
Other Working Capital | 373 | 502 | 340 | -290 | 860 |
Other Operating Activity | 1,502 | 1,175 | 889 | 1,327 | 3,131 |
Operating Cash Flow | $-8,262 | $-5,373 | $-3,120 | $-9,451 | $-7,127 |
Cash Flows From Investing Activities | |||||
Other Investing Activity | 0 | 0 | 0 | -3,000 | -3,000 |
Investing Cash Flow | $N/A | $N/A | $N/A | $-3,000 | $-3,000 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 10,283 | 9,716 | 4,973 | 7,526 | 3,651 |
Other Financing Activity | -1,207 | -1,207 | -442 | 0 | -71 |
Financing Cash Flow | $9,076 | $8,509 | $4,531 | $7,526 | $3,580 |
Beginning Cash Position | 1,783 | 1,783 | 1,783 | 6,708 | 6,708 |
End Cash Position | 2,597 | 4,919 | 3,194 | 1,783 | 161 |
Net Cash Flow | $814 | $3,136 | $1,411 | $-4,925 | $-6,547 |
Free Cash Flow | |||||
Operating Cash Flow | -8,262 | -5,373 | -3,120 | -9,451 | -7,127 |
Free Cash Flow | -8,262 | -5,373 | -3,120 | -9,451 | -7,127 |